---
$id: https://graph.org.ai/products/commodity/51152024
$type: Product
source: UNSPSC
code: "51152024"
title: "Dantrolene sodium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dantrolene sodium

**UNSPSC Code**: 51152024
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 287M0347EV. European Medicines Agency schedules Dantrolene sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01553MIG. Dantrolene sodium generally arises in the molecular formula C14H9N4NAO5. The term DANTROLENE SODIUM is a United States Adopted Name designation. Most nations schedule dantrolene sodium under HS 29349990 and SITC 51579. As of Q4 2014, DANTROLENE SODIUM remains the US FDA Preferred Term for this commodity. Dantrolene sodium bears US NLM identifiers UMLS ID C0010977 and NCI Concept Code C61698. SMILES: C1C(=O)N=C(N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[NA+].

